Product Information
ETODOLAC ER 600 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $1.0728 per EA under NDC 68382027314. Its NADAC has been published 520 times since Nov 26, 2014.
FDA first approved this application on Jan 23, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382027314
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ETODOLACApproval Type
Generic (ANDA)
FDA Application
ANDA091134FDA Approved
1/23/2014
TE Code
AB
On Market Since
2/15/2014
Pharmacological Classes
Price Statistics
The NADAC for ETODOLAC ER 600 MG TABLET has been published 520 times since Nov 26, 2014, and over the history we have for it it has declined 54.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0728 per EA |
|---|---|
| All-time high | $2.7019 (Apr 15, 2015) |
| All-time low | $0.9697 (Mar 19, 2025) |
| 52-week high | $1.1738 |
| 52-week low | $1.0255 |
| Median price | $2.0502 |
| Average price | $1.9233 |
| Largest weekly change | -23.6% (Jul 17, 2019) |
| Weeks tracked | 520 |
| Tracking since | Nov 26, 2014 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Etodolac market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ETODOLAC ER 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ETODOLAC ER 600 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $1.0728 per EA (NDC 68382027314), effective Sep 30, 2026.
How has the price of ETODOLAC ER 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for ETODOLAC ER 600 MG TABLET has declined 54.9%. It has been tracked across 520 weekly CMS publications since Nov 26, 2014.
What are the highest and lowest recorded NADAC prices for ETODOLAC ER 600 MG TABLET?
Since Nov 26, 2014, the NADAC for ETODOLAC ER 600 MG TABLET has ranged from a low of $0.9697 (Mar 19, 2025) to a high of $2.7019 (Apr 15, 2015), with a median of $2.0502 per EA.
Are there cheaper alternatives to ETODOLAC ER 600 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ETODOLAC ER 600 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ETODOLAC ER 600 MG TABLET?
ETODOLAC ER 600 MG TABLET (NDC 68382027314) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.